Investor · 1 deal
Every published round Nick McCooke took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Longas | Unnamed stage | 16 May 2019 | - | Participant | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Companies Nick McCooke has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Longas | 16 May 2019 | 1 | 0 |
Fund closes reported for Nick McCooke, as distinct from the investments it has made.
Companies Nick McCooke has backed that another company then bought. An exit for the holding, not a deal Nick McCooke did.
Stories naming Nick McCooke. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A university spin-out launches with venture and founder backing, introducing a technology that extends DNA sequencing read lengths, and appointing a new chief executive to commercialise it.